Product name | Recombinant Human FcRn/FCGRT&B2M Protein |
---|---|
Catalog No. | RP01037 |
Description | Recombinant Human FcRn/FCGRT&B2M Protein is produced by HEK293 cells expression system. The target heterodimer proteins are co-expressed with the sequence (Ala24-Ser297) of human FCGRT (Accession #NP_004098.1) fused with a 6×His tag at the C-terminus and the sequence (Ile21-Met119) of human B2M (Accession #NP_004039.1). |
Bio-Activity | 1.Measured by its binding ability in a functional ELISA. Immobilized Human FCGRT&B2M at 5 μg/mL (100 μL/well) can bind biotinylated human IgG1 with a linear range of 1-6μg/mL. 2.Immobilized Trastuzumab on COOH Chip can bind Human FCGRT&B2M Heterodimer Protein with an affinity constant of 0.22 μM as determined in a SPR assay (OpenSPR). |
Purity | > 97% by SDS-PAGE. |
Endotoxin | < 0.1 EU/μg of the protein by LAL method. |
Formulation | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation. |
Species | Human |
Calculated MW | 30.38 kDa(FCGRT), 11.73 kDa(B2M) |
Synonym | FCRN |
---|---|
Expression Host | HEK293 cells |
Tag | C-His(FCGRT)&No tag(B2M) |
Swiss-Prot | |
Gene ID |
Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|---|
Reconstitution | Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
* For research use only. Not for therapeutic or diagnostic purposes.